Logo image of ALTM

Arcadium Lithium plc (ALTM) Stock Fundamental Analysis

NYSE:ALTM - New York Stock Exchange, Inc. - JE00BM9HZ112 - Common Stock - Currency: USD

5.84  0 (0%)

After market: 5.84 0 (0%)

Fundamental Rating

4

Overall ALTM gets a fundamental rating of 4 out of 10. We evaluated ALTM against 85 industry peers in the Chemicals industry. There are concerns on the financial health of ALTM while its profitability can be described as average. ALTM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ALTM had positive earnings in the past year.
In the past year ALTM has reported a negative cash flow from operations.
Of the past 5 years ALTM 4 years were profitable.
Of the past 5 years ALTM 4 years had a positive operating cash flow.
ALTM Yearly Net Income VS EBIT VS OCF VS FCFALTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

ALTM has a Return On Assets (1.01%) which is comparable to the rest of the industry.
With a Return On Equity value of 1.65%, ALTM perfoms like the industry average, outperforming 45.88% of the companies in the same industry.
ALTM's Return On Invested Capital of 2.86% is on the low side compared to the rest of the industry. ALTM is outperformed by 63.53% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALTM is in line with the industry average of 7.03%.
The 3 year average ROIC (8.50%) for ALTM is well above the current ROIC(2.86%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.01%
ROE 1.65%
ROIC 2.86%
ROA(3y)8.14%
ROA(5y)4.55%
ROE(3y)13.03%
ROE(5y)7.26%
ROIC(3y)8.5%
ROIC(5y)N/A
ALTM Yearly ROA, ROE, ROICALTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

ALTM's Profit Margin of 10.24% is amongst the best of the industry. ALTM outperforms 88.24% of its industry peers.
In the last couple of years the Profit Margin of ALTM has declined.
ALTM has a Operating Margin of 36.16%. This is amongst the best in the industry. ALTM outperforms 96.47% of its industry peers.
ALTM's Operating Margin has improved in the last couple of years.
ALTM has a better Gross Margin (49.37%) than 92.94% of its industry peers.
ALTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 36.16%
PM (TTM) 10.24%
GM 49.37%
OM growth 3Y339.85%
OM growth 5Y12.09%
PM growth 3Y315.53%
PM growth 5Y-4.55%
GM growth 3Y27%
GM growth 5Y9.04%
ALTM Yearly Profit, Operating, Gross MarginsALTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

2

2. Health

2.1 Basic Checks

ALTM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ALTM has been increased compared to 1 year ago.
ALTM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALTM is higher compared to a year ago.
ALTM Yearly Shares OutstandingALTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ALTM Yearly Total Debt VS Total AssetsALTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

ALTM has an Altman-Z score of 1.29. This is a bad value and indicates that ALTM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALTM (1.29) is worse than 68.24% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that ALTM is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.11, ALTM belongs to the best of the industry, outperforming 83.53% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACC0.4
WACC7.06%
ALTM Yearly LT Debt VS Equity VS FCFALTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

ALTM has a Current Ratio of 1.09. This is a normal value and indicates that ALTM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.09, ALTM is doing worse than 83.53% of the companies in the same industry.
ALTM has a Quick Ratio of 1.09. This is a bad value and indicates that ALTM is not financially healthy enough and could expect problems in meeting its short term obligations.
ALTM has a worse Quick ratio (0.56) than 83.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.56
ALTM Yearly Current Assets VS Current LiabilitesALTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

ALTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.56%.
The earnings per share for ALTM have been decreasing by -77.97% on average. This is quite bad
Looking at the last year, ALTM shows a quite strong growth in Revenue. The Revenue has grown by 14.20% in the last year.
Measured over the past years, ALTM shows a very strong growth in Revenue. The Revenue has been growing by 21.01% on average per year.
EPS 1Y (TTM)-94.56%
EPS 3YN/A
EPS 5Y-77.97%
EPS Q2Q%-97.06%
Revenue 1Y (TTM)14.2%
Revenue growth 3Y33.84%
Revenue growth 5Y21.01%
Sales Q2Q%58.97%

3.2 Future

The Earnings Per Share is expected to grow by 53.89% on average over the next years. This is a very strong growth
ALTM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.62% yearly.
EPS Next Y11.36%
EPS Next 2Y51.71%
EPS Next 3Y62.79%
EPS Next 5Y53.89%
Revenue Next Year15.71%
Revenue Next 2Y16.95%
Revenue Next 3Y27.33%
Revenue Next 5Y16.62%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALTM Yearly Revenue VS EstimatesALTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
ALTM Yearly EPS VS EstimatesALTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50 100 150 200 250

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALTM is valuated quite expensively with a Price/Earnings ratio of 44.92.
ALTM's Price/Earnings ratio is a bit more expensive when compared to the industry. ALTM is more expensive than 65.88% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALTM to the average of the S&P500 Index (26.19), we can say ALTM is valued expensively.
Based on the Price/Forward Earnings ratio of 40.34, the valuation of ALTM can be described as expensive.
ALTM's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ALTM is more expensive than 68.24% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, ALTM is valued quite expensively.
Industry RankSector Rank
PE 44.92
Fwd PE 40.34
ALTM Price Earnings VS Forward Price EarningsALTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALTM is valued a bit more expensive than 62.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.62
ALTM Per share dataALTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALTM does not grow enough to justify the current Price/Earnings ratio.
ALTM has a very decent profitability rating, which may justify a higher PE ratio.
ALTM's earnings are expected to grow with 62.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.95
PEG (5Y)N/A
EPS Next 2Y51.71%
EPS Next 3Y62.79%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALTM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Arcadium Lithium plc

NYSE:ALTM (3/5/2025, 8:04:00 PM)

After market: 5.84 0 (0%)

5.84

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners71.08%
Inst Owner Change4.9%
Ins Owners0.22%
Ins Owner Change-262.12%
Market Cap6.27B
Analysts70
Price Target6.03 (3.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-39.28%
Min EPS beat(2)-74.86%
Max EPS beat(2)-3.69%
EPS beat(4)1
Avg EPS beat(4)-11.38%
Min EPS beat(4)-74.86%
Max EPS beat(4)34.36%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-10.28%
Min Revenue beat(2)-25.87%
Max Revenue beat(2)5.31%
Revenue beat(4)2
Avg Revenue beat(4)-7.56%
Min Revenue beat(4)-25.87%
Max Revenue beat(4)5.31%
Revenue beat(8)5
Avg Revenue beat(8)295.85%
Revenue beat(12)9
Avg Revenue beat(12)401.08%
Revenue beat(16)13
Avg Revenue beat(16)354.95%
PT rev (1m)0%
PT rev (3m)-3.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)119.38%
EPS NY rev (1m)0%
EPS NY rev (3m)1.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.96%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)-5.29%
Valuation
Industry RankSector Rank
PE 44.92
Fwd PE 40.34
P/S 6.22
P/FCF N/A
P/OCF N/A
P/B 1
P/tB 1.3
EV/EBITDA 14.62
EPS(TTM)0.13
EY2.23%
EPS(NY)0.14
Fwd EY2.48%
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.94
BVpS5.83
TBVpS4.5
PEG (NY)3.95
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.01%
ROE 1.65%
ROCE 3.88%
ROIC 2.86%
ROICexc 2.89%
ROICexgc 3.41%
OM 36.16%
PM (TTM) 10.24%
GM 49.37%
FCFM N/A
ROA(3y)8.14%
ROA(5y)4.55%
ROE(3y)13.03%
ROE(5y)7.26%
ROIC(3y)8.5%
ROIC(5y)N/A
ROICexc(3y)10.83%
ROICexc(5y)N/A
ROICexgc(3y)11.51%
ROICexgc(5y)N/A
ROCE(3y)11.53%
ROCE(5y)N/A
ROICexcg growth 3Y191.49%
ROICexcg growth 5Y-15.97%
ROICexc growth 3Y175.9%
ROICexc growth 5Y-18.7%
OM growth 3Y339.85%
OM growth 5Y12.09%
PM growth 3Y315.53%
PM growth 5Y-4.55%
GM growth 3Y27%
GM growth 5Y9.04%
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 1.38
Cap/Depr 841.13%
Cap/Sales 103.49%
Interest Coverage 12.57
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.56
Altman-Z 1.29
F-Score2
WACC7.06%
ROIC/WACC0.4
Cap/Depr(3y)1054.15%
Cap/Depr(5y)836.79%
Cap/Sales(3y)60.66%
Cap/Sales(5y)51.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.56%
EPS 3YN/A
EPS 5Y-77.97%
EPS Q2Q%-97.06%
EPS Next Y11.36%
EPS Next 2Y51.71%
EPS Next 3Y62.79%
EPS Next 5Y53.89%
Revenue 1Y (TTM)14.2%
Revenue growth 3Y33.84%
Revenue growth 5Y21.01%
Sales Q2Q%58.97%
Revenue Next Year15.71%
Revenue Next 2Y16.95%
Revenue Next 3Y27.33%
Revenue Next 5Y16.62%
EBIT growth 1Y-8.97%
EBIT growth 3Y488.68%
EBIT growth 5Y35.64%
EBIT Next Year99.7%
EBIT Next 3Y72.01%
EBIT Next 5Y51.11%
FCF growth 1Y-3990.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-159.2%
OCF growth 3YN/A
OCF growth 5YN/A